| Position | Action |
|---|---|
| Full position reduction | Trim existing PEP exposure to no more than 50% of typical consumer staples allocation |
| Capital redeployment - core yield | 50-60% into short-duration investment-grade credit yielding 4%+ |
| Capital redeployment - defensive staple | 20-30% into MO as a cleaner defensive staple with better balance sheet |
| Capital redeployment - dry powder | Remainder as cash/T-bill dry powder |
| Hard stop trigger | Daily close below $137.15 on volume >6M confirms bear case; open path to $133.73 (52-week low) and $130 |
PEP is a buyable base at $139 with a coiled-spring technical setup and mechanical earnings recovery already priced into a 15.48 forward P/E, offering a 5:1 reward-to-risk ratio with 4.28% yield as macro tailwind.
| Indicator | Value | Signal |
|---|---|---|
| close | 139.02 | neutral |
| 10_ema | 139.11 | bearish |
| 50_sma | 140.39 | bearish |
| 200_sma | 147.34 | bearish |
| rsi_14 | 48.66 | neutral |
| macd | -0.36 | bullish |
| macd_histogram | +0.23 | bullish |
| bollinger_upper | 143.20 | neutral |
| bollinger_mid | 138.22 | neutral |
| bollinger_lower | 133.25 | neutral |
| atr_14 | 3.14 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Underweight PEP: Trim to 50% allocation via tranche execution, rotate to IG credit/MO/cash, hard stop at $137.15
The bear's structural arguments (1.00x FCF-to-dividend coverage with zero buffer, $2B 2025 impairment signaling management disbelief in M&A cash flows, $40B net debt with 37% interest expense increase in two years, private-label secular headwinds, GLP-1 multi-year drag) are more durable than the bull's tactical micro-recovery stories (Alvalau at 0.1% of revenue, Suja at $335M). Three counterweights prevent full Sell conviction: (1) 4.28% yield with 0.36 beta provides defensive cushion historically cushioning 5-6% drawdowns; (2) forward P/E of 15.48 vs. TTM 18.22 prices in ~17% earnings recovery, limiting some downside; (3) CapEx stepping down from $5.5B to $4.4B is structural FCF expansion de-risking dividend coverage over 12-18 months. The 50+ year dividend growth streak and board's multiple levers (buybacks, capex flexibility, asset sales) make the dividend fragile but not imminent. Execution: 3-5 day tranche pace via limit orders at $139.80-$140.20 to avoid chasing into volume days.
PEP and KO are not structurally comparable; 54% of revenue comes from Frito-Lay and Quaker (food), not cola; Frito-Lay owns ~60% of U.S. salty-snack category and Gatorade owns ~75% of sports-drink market, creating moats KO cannot replicate
· concedes: KO has brand-mind-share edge in cola that PEP cannot deny; The payout ratio at 1.00x is tight and leaves no margin of safety; Revenue growth has decelerated to ~2% headline
PEP is not a coiled spring but a stock in structural decline with a broken dividend story, an evaporating competitive moat, and a technical setup that has historically failed roughly 60% of the time in deteriorating-trend contexts.
· concedes: Q2 Suja growth of +11.6% is good (though off a small base); PEP and KO are technically different businesses with different revenue mixes; 7-Eleven $1.99 soda alone is a rounding error (the threat is collective); ATR compression does indicate a regime change is coming (direction unknown)
→ vs conservative: 4.28% yield with 1.00x FCF coverage is not a defensive cushion but a margin of error; payout ratio at risk creates high-yield compression event risk of 15-20% equity drop, not gradual derating
→ vs conservative: Beta of 0.36 provides no downside protection when stock is already down 19% from highs; low beta in a falling knife means bleeding out slowly
→ vs neutral: MACD histogram divergence is a bull trap in a downtrend, not a bullish reversal; ATR compression at 3.14 resolves to downside in bearish regime
→ vs neutral: Volume of 4.59M shares is the lightest in weeks, characteristic of distribution as institutions quietly exit into retail indifference
→ vs neutral: Forward P/E of 15.48 with 17% earnings recovery is analyst hope, not grounded in operating reality given volume decline, eroding pricing power, and sticky input costs
→ vs neutral: Upside to 143-147 requires daily close above 140.39 on rising volume with MACD crossing signal; none of these confirmations have triggered
| volume | 4.59M | neutral |
Support: 138.22 · 135.4 · 133.25 | Resistance: 140.39 · 143.2 · 147.34
PEP closed at 139.02, sitting essentially on the 10 EMA (139.11) with the 50 SMA (140.39) declining overhead and the 200 SMA (147.34) remaining a major long-term ceiling 5.6% above price. RSI is neutral at 48.66 with no directional edge, while the MACD histogram has been positive for 8 straight sessions showing bullish momentum divergence even as MACD remains negative at -0.36. ATR has compressed to 3.14 (down from 3.84 on 07-09), indicating a coiled volatility setup that should resolve with a directional break soon. The recommended action is HOLD with a tactical bullish bias on confirmation above 140.4 (50 SMA reclaim) or a successful retest of 135.4 support; new entrants should wait for confirmed signals rather than bet directionally in this range-bound environment.
Market Capitalization
$189.9 billion
Current Price (implied)
~$138.96
52-Week High
$171.48
52-Week Low
$133.73
50-Day Moving Average
$141.32
200-Day Moving Average
$149.69
TTM P/E Ratio
18.22
Forward P/E Ratio
15.48
PEG Ratio
1.5
Price-to-Book
8.59
Beta
0.361
Dividend Yield
4.28%
FY2025 Revenue
$93.925 billion
FY2024 Revenue
$91.854 billion
FY2023 Revenue
$91.471 billion
FY2022 Revenue
$86.392 billion
Gross Profit 2025
$50.86 billion
Operating Income 2025
$11.50 billion
EBITDA 2025
$15.54 billion
Net Income 2025
$8.24 billion
Diluted EPS 2025
$6.00
Forward EPS
$8.98
Impairment Charge 2025
$1.993 billion
Gross Margin
~54.2%
Operating Margin
16.84%
Profit Margin
10.79%
Effective Tax Rate
~19.0%
Interest Expense 2025
$1.121 billion
Total Assets
$107.40 billion
Cash & Equivalents
$9.16 billion
Total Current Assets
$27.95 billion
Net PPE
$33.65 billion
Goodwill & Intangibles
$33.98 billion
Total Current Liabilities
$32.76 billion
Long-Term Debt
$42.32 billion
Current Debt
$6.86 billion
Total Debt
$49.90 billion
Net Debt
$40.02 billion
Total Stockholders' Equity
$20.41 billion
Treasury Stock
$41.83 billion
Debt-to-Equity (Book)
2.39
Debt/Total Capitalization
~67.5%
Current Ratio
0.934
Working Capital
-$4.82 billion
Goodwill
$18.92 billion
Operating Cash Flow 2025
$12.087 billion
CapEx 2025
$4.415 billion
Free Cash Flow 2025
$7.672 billion
Cash Dividends Paid 2025
$7.638 billion
Share Repurchases 2025
$1.000 billion
Acquisitions (Net) 2025
$3.352 billion
FCF / Dividend Coverage
1.00x
ROE TTM
51.51%
ROA
8.93%
ROIC (estimated)
~15-17%
Payout Ratio
~92.7%
Total Capital Return 2025
~$8.64 billion
Strengths
Concerns
PepsiCo is a mega-cap Consumer Defensive company trading near its 52-week low with an attractive 4.28% dividend yield and very low beta (0.36), making it a solid defensive income play. However, FY2025 results were pressured by a $1.993 billion impairment charge that drove net income down 14% to $8.24B, while free cash flow of $7.67B barely covered the $7.64B dividend payout (1.00x coverage). The forward P/E of 15.48 suggests analysts expect significant earnings recovery, but the tight FCF coverage, elevated net debt of $40.02B, and slow ~2% revenue growth warrant caution before initiating new positions.